

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * detection of light stimulus (GO:0009583) | 9.64862887 |
| 2 | detection of visible light (GO:0009584) | 9.62217984 |
| 3 | * visual perception (GO:0007601) | 8.67027988 |
| 4 | * sensory perception of light stimulus (GO:0050953) | 8.56270880 |
| 5 | protein-chromophore linkage (GO:0018298) | 8.47142674 |
| 6 | positive regulation of guanylate cyclase activity (GO:0031284) | 8.32701230 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 7.41709050 |
| 8 | cellular response to light stimulus (GO:0071482) | 7.29351499 |
| 9 | retina development in camera-type eye (GO:0060041) | 7.20797960 |
| 10 | photoreceptor cell differentiation (GO:0046530) | 6.93662216 |
| 11 | eye photoreceptor cell differentiation (GO:0001754) | 6.93662216 |
| 12 | * detection of external stimulus (GO:0009581) | 6.63970439 |
| 13 | * detection of abiotic stimulus (GO:0009582) | 6.49272255 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 6.01906151 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 6.01906151 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.01906151 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.01906151 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.01906151 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 6.01906151 |
| 20 | negative regulation of cell killing (GO:0031342) | 5.95804005 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.95804005 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.76209862 |
| 23 | regulation of cGMP metabolic process (GO:0030823) | 5.68597420 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.52685309 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.47604174 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.35725782 |
| 27 | detection of other organism (GO:0098543) | 5.19457495 |
| 28 | detection of bacterium (GO:0016045) | 5.18288995 |
| 29 | adaptation of signaling pathway (GO:0023058) | 5.15712536 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.01588590 |
| 31 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.00906618 |
| 32 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.89574040 |
| 33 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.75068930 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 4.73677685 |
| 35 | response to peptidoglycan (GO:0032494) | 4.69968620 |
| 36 | respiratory burst (GO:0045730) | 4.67055510 |
| 37 | cellular response to radiation (GO:0071478) | 4.61934659 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.53337850 |
| 39 | regulation of cGMP biosynthetic process (GO:0030826) | 4.53030330 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 4.53006734 |
| 41 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.44200691 |
| 42 | leukocyte aggregation (GO:0070486) | 4.36200687 |
| 43 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.35154178 |
| 44 | positive regulation of cGMP metabolic process (GO:0030825) | 4.34253841 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 4.32159376 |
| 46 | nonmotile primary cilium assembly (GO:0035058) | 4.21766515 |
| 47 | detection of external biotic stimulus (GO:0098581) | 4.20376059 |
| 48 | response to host immune response (GO:0052572) | 4.11388944 |
| 49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.11388944 |
| 50 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.10587789 |
| 51 | negative regulation of interleukin-12 production (GO:0032695) | 4.09682678 |
| 52 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.01286346 |
| 53 | * sensory perception (GO:0007600) | 4.00134525 |
| 54 | estrogen biosynthetic process (GO:0006703) | 3.98330234 |
| 55 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.96226331 |
| 56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.92927487 |
| 57 | prenylation (GO:0097354) | 3.89801696 |
| 58 | protein prenylation (GO:0018342) | 3.89801696 |
| 59 | response to interleukin-15 (GO:0070672) | 3.89782077 |
| 60 | neutrophil activation (GO:0042119) | 3.89344160 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.87613476 |
| 62 | detection of biotic stimulus (GO:0009595) | 3.85900956 |
| 63 | neuron development (GO:0048666) | 3.85641746 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.83475979 |
| 65 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.82859672 |
| 66 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.80054345 |
| 67 | response to host (GO:0075136) | 3.80054345 |
| 68 | response to host defenses (GO:0052200) | 3.80054345 |
| 69 | * response to light stimulus (GO:0009416) | 3.78469300 |
| 70 | cellular extravasation (GO:0045123) | 3.75057547 |
| 71 | regulation of gamma-delta T cell activation (GO:0046643) | 3.73388710 |
| 72 | response to muramyl dipeptide (GO:0032495) | 3.72692940 |
| 73 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.71632385 |
| 74 | detection of molecule of bacterial origin (GO:0032490) | 3.70805046 |
| 75 | B cell receptor signaling pathway (GO:0050853) | 3.70292952 |
| 76 | cellular response to interleukin-15 (GO:0071350) | 3.69227464 |
| 77 | response to pheromone (GO:0019236) | 3.68215153 |
| 78 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.61545121 |
| 79 | granulocyte activation (GO:0036230) | 3.59458790 |
| 80 | retina homeostasis (GO:0001895) | 3.52453254 |
| 81 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.52174209 |
| 82 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.50724956 |
| 83 | defense response to protozoan (GO:0042832) | 3.49569459 |
| 84 | regulation of mast cell degranulation (GO:0043304) | 3.47885229 |
| 85 | neutrophil mediated immunity (GO:0002446) | 3.46165449 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 3.44476293 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43959627 |
| 88 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.40745844 |
| 89 | cellular response to type I interferon (GO:0071357) | 3.40132182 |
| 90 | type I interferon signaling pathway (GO:0060337) | 3.40132182 |
| 91 | negative regulation of phagocytosis (GO:0050765) | 3.39897304 |
| 92 | negative thymic T cell selection (GO:0045060) | 3.37674557 |
| 93 | regulation of B cell differentiation (GO:0045577) | 3.35218413 |
| 94 | retina layer formation (GO:0010842) | 3.34296539 |
| 95 | response to type I interferon (GO:0034340) | 3.34133266 |
| 96 | B cell mediated immunity (GO:0019724) | 3.33679807 |
| 97 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.30784781 |
| 98 | positive regulation of mast cell activation (GO:0033005) | 3.27946753 |
| 99 | NIK/NF-kappaB signaling (GO:0038061) | 3.27707496 |
| 100 | positive thymic T cell selection (GO:0045059) | 3.26871031 |
| 101 | negative regulation of T cell mediated immunity (GO:0002710) | 3.24940326 |
| 102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.22322613 |
| 103 | protein localization to synapse (GO:0035418) | 3.21153006 |
| 104 | microglial cell activation (GO:0001774) | 3.19842797 |
| 105 | synaptic vesicle maturation (GO:0016188) | 3.17977958 |
| 106 | macrophage activation (GO:0042116) | 3.17342275 |
| 107 | regulation of T cell tolerance induction (GO:0002664) | 3.16845094 |
| 108 | response to protozoan (GO:0001562) | 3.16804802 |
| 109 | negative T cell selection (GO:0043383) | 3.15749483 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.14073713 |
| 111 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.11889065 |
| 112 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.11655676 |
| 113 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10514937 |
| 114 | regulation of penile erection (GO:0060405) | 3.10408666 |
| 115 | T cell migration (GO:0072678) | 3.09392162 |
| 116 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.09183369 |
| 117 | germinal center formation (GO:0002467) | 3.09090663 |
| 118 | post-embryonic morphogenesis (GO:0009886) | 3.08553835 |
| 119 | phospholipid translocation (GO:0045332) | 3.08400390 |
| 120 | lipid translocation (GO:0034204) | 3.08400390 |
| 121 | regulation of leukocyte degranulation (GO:0043300) | 3.02555087 |
| 122 | tolerance induction (GO:0002507) | 3.01966406 |
| 123 | positive regulation of B cell differentiation (GO:0045579) | 3.00654547 |
| 124 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00574497 |
| 125 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.99894803 |
| 126 | myeloid leukocyte mediated immunity (GO:0002444) | 2.97655728 |
| 127 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.97237974 |
| 128 | myeloid dendritic cell differentiation (GO:0043011) | 2.95934356 |
| 129 | positive regulation of neurotransmitter transport (GO:0051590) | 2.95548644 |
| 130 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.95466586 |
| 131 | T cell selection (GO:0045058) | 2.94812699 |
| 132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.94300878 |
| 133 | leukocyte degranulation (GO:0043299) | 2.92983684 |
| 134 | thymic T cell selection (GO:0045061) | 2.92971273 |
| 135 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.92659426 |
| 136 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.92659426 |
| 137 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.92319228 |
| 138 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.92206700 |
| 139 | regulation of mast cell activation (GO:0033003) | 2.91535550 |
| 140 | negative regulation of innate immune response (GO:0045824) | 2.89615728 |
| 141 | regulation of tolerance induction (GO:0002643) | 2.88693729 |
| 142 | positive regulation of type 2 immune response (GO:0002830) | 2.88029657 |
| 143 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.86413425 |
| 144 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.85640299 |
| 145 | sodium ion export (GO:0071436) | 2.84922917 |
| 146 | myeloid dendritic cell activation (GO:0001773) | 2.84490373 |
| 147 | retinoid metabolic process (GO:0001523) | 2.84233644 |
| 148 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83772237 |
| 149 | B cell homeostasis (GO:0001782) | 2.77632614 |
| 150 | regulation of regulated secretory pathway (GO:1903305) | 2.77146072 |
| 151 | positive regulation of vesicle fusion (GO:0031340) | 2.73943428 |
| 152 | membrane hyperpolarization (GO:0060081) | 2.73427626 |
| 153 | cellular potassium ion homeostasis (GO:0030007) | 2.62247263 |
| 154 | response to histamine (GO:0034776) | 2.62068406 |
| 155 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.60374540 |
| 156 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.60374540 |
| 157 | * response to radiation (GO:0009314) | 2.56697359 |
| 158 | diterpenoid metabolic process (GO:0016101) | 2.56605129 |
| 159 | behavioral response to ethanol (GO:0048149) | 2.55595351 |
| 160 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.55039797 |
| 161 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.51732976 |
| 162 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.51150079 |
| 163 | dopamine receptor signaling pathway (GO:0007212) | 2.48407993 |
| 164 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.47553024 |
| 165 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.46452483 |
| 166 | mitochondrion transport along microtubule (GO:0047497) | 2.46452483 |
| 167 | axoneme assembly (GO:0035082) | 2.45535226 |
| 168 | negative regulation of cation channel activity (GO:2001258) | 2.45530485 |
| 169 | retinol metabolic process (GO:0042572) | 2.37571593 |
| 170 | cellular response to abiotic stimulus (GO:0071214) | 2.36576671 |
| 171 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.31920680 |
| 172 | potassium ion export (GO:0071435) | 2.31647521 |
| 173 | terpenoid metabolic process (GO:0006721) | 2.30057950 |
| 174 | potassium ion homeostasis (GO:0055075) | 2.29986081 |
| 175 | protein heterotetramerization (GO:0051290) | 2.29713274 |
| 176 | short-term memory (GO:0007614) | 2.29480877 |
| 177 | positive regulation of gastrulation (GO:2000543) | 2.26602598 |
| 178 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.24932532 |
| 179 | vitamin A metabolic process (GO:0006776) | 2.24805610 |
| 180 | lactate metabolic process (GO:0006089) | 2.23164012 |
| 181 | arachidonic acid secretion (GO:0050482) | 2.21824560 |
| 182 | icosanoid secretion (GO:0032309) | 2.21824560 |
| 183 | synaptic vesicle exocytosis (GO:0016079) | 2.17585580 |
| 184 | regulation of transcription regulatory region DNA binding (GO:2000677) | 2.16799842 |
| 185 | positive regulation of cyclase activity (GO:0031281) | 2.16197126 |
| 186 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.13812880 |
| 187 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.13812880 |
| 188 | chemosensory behavior (GO:0007635) | 2.13791189 |
| 189 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 17.1021736 |
| 190 | rhodopsin mediated signaling pathway (GO:0016056) | 16.7511265 |
| 191 | retinal cone cell development (GO:0046549) | 14.1317509 |
| 192 | photoreceptor cell development (GO:0042461) | 12.8386152 |
| 193 | photoreceptor cell maintenance (GO:0045494) | 12.1192933 |
| 194 | eye photoreceptor cell development (GO:0042462) | 12.0240109 |
| 195 | retinal rod cell development (GO:0046548) | 11.0132134 |
| 196 | detection of light stimulus involved in visual perception (GO:0050908) | 10.4594142 |
| 197 | detection of light stimulus involved in sensory perception (GO:0050962) | 10.4594142 |
| 198 | GMP metabolic process (GO:0046037) | 10.3887487 |
| 199 | * phototransduction (GO:0007602) | 10.1708556 |
| 200 | phototransduction, visible light (GO:0007603) | 10.0862080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 4.33802170 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.84121958 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.77105599 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.58762332 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.18876888 |
| 6 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.07921154 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.98902615 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89129571 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.77252092 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.74916053 |
| 11 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.68787847 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.59890037 |
| 13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.43334053 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40847929 |
| 15 | KDM2B_26808549_Chip-Seq_K562_Human | 2.37347436 |
| 16 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.33895955 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.32278019 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29840722 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.25197432 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.22898758 |
| 21 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.22578431 |
| 22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.22117760 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20248318 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.20083630 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.19417571 |
| 26 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11538497 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.11465307 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10483807 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02615440 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00659119 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.99682012 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98493482 |
| 33 | P68_20966046_ChIP-Seq_HELA_Human | 1.96363578 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.94359705 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93157532 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92976920 |
| 37 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.91286333 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89320747 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86950341 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84852403 |
| 41 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.81325742 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.81128412 |
| 43 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.78256175 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.78201169 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.76724716 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76340767 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75866601 |
| 48 | MYB_26560356_Chip-Seq_TH2_Human | 1.75342097 |
| 49 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.74790185 |
| 50 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.71352780 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66674408 |
| 52 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.66359176 |
| 53 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.66060367 |
| 54 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.64074897 |
| 55 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.62841835 |
| 56 | MYB_26560356_Chip-Seq_TH1_Human | 1.60905292 |
| 57 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.53878890 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52302550 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51783223 |
| 60 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.50435148 |
| 61 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48593288 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.48309218 |
| 63 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47566614 |
| 64 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47238923 |
| 65 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.46662956 |
| 66 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43051761 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42911168 |
| 68 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41537056 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41221741 |
| 70 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39375790 |
| 71 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39324111 |
| 72 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.39215751 |
| 73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38717453 |
| 74 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.38199203 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.37765525 |
| 76 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.36212479 |
| 77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.35271910 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35105877 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34793435 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33430254 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31932763 |
| 82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31861320 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30447985 |
| 84 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29935439 |
| 85 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.29348676 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29138539 |
| 87 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28344138 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27070691 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25485562 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25464862 |
| 91 | MAF_26560356_Chip-Seq_TH1_Human | 1.25325526 |
| 92 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.24819873 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23982186 |
| 94 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23886838 |
| 95 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 1.23251114 |
| 96 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.22643607 |
| 97 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.22568749 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22014333 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21516176 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20039578 |
| 101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19882792 |
| 102 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19573991 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19489068 |
| 104 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19202256 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18343721 |
| 106 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18112494 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16915690 |
| 108 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16491584 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15241817 |
| 110 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14767186 |
| 111 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14649524 |
| 112 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14610913 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11983933 |
| 114 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11591877 |
| 115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10488511 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10118401 |
| 117 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.09271877 |
| 118 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.08672951 |
| 119 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.08237592 |
| 120 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08158660 |
| 121 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07425020 |
| 122 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07273078 |
| 123 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06417941 |
| 124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04185528 |
| 125 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02945939 |
| 126 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02246269 |
| 127 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.02218355 |
| 128 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.00991178 |
| 129 | * MAF_26560356_Chip-Seq_TH2_Human | 1.00666233 |
| 130 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00222136 |
| 131 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00051442 |
| 132 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99413600 |
| 133 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.99388836 |
| 134 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.98554682 |
| 135 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98442058 |
| 136 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97920507 |
| 137 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.96661724 |
| 138 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96634180 |
| 139 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96581117 |
| 140 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95837736 |
| 141 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95397094 |
| 142 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94776802 |
| 143 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94522675 |
| 144 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.94509132 |
| 145 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.94441099 |
| 146 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94164808 |
| 147 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93936367 |
| 148 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.93271939 |
| 149 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.91928608 |
| 150 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91832583 |
| 151 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91648594 |
| 152 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.90846968 |
| 153 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.90761251 |
| 154 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87589005 |
| 155 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.85897840 |
| 156 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85667770 |
| 157 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85375448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005551_abnormal_eye_electrophysiolog | 9.11609797 |
| 2 | MP0005253_abnormal_eye_physiology | 6.87289044 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.81717697 |
| 4 | MP0003724_increased_susceptibility_to | 4.09402383 |
| 5 | * MP0005195_abnormal_posterior_eye | 3.80860669 |
| 6 | MP0005671_abnormal_response_to | 3.73799269 |
| 7 | MP0008260_abnormal_autophagy | 3.52519341 |
| 8 | MP0005391_vision/eye_phenotype | 3.49252135 |
| 9 | * MP0001324_abnormal_eye_pigmentation | 3.30719412 |
| 10 | MP0001800_abnormal_humoral_immune | 3.18671353 |
| 11 | MP0000685_abnormal_immune_system | 3.13421813 |
| 12 | MP0005387_immune_system_phenotype | 3.04216813 |
| 13 | MP0001790_abnormal_immune_system | 3.04216813 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.98475855 |
| 15 | MP0002638_abnormal_pupillary_reflex | 2.95415288 |
| 16 | MP0002419_abnormal_innate_immunity | 2.93109936 |
| 17 | MP0003950_abnormal_plasma_membrane | 2.84559958 |
| 18 | MP0005025_abnormal_response_to | 2.82311554 |
| 19 | MP0002090_abnormal_vision | 2.82275850 |
| 20 | MP0009785_altered_susceptibility_to | 2.74074533 |
| 21 | MP0002723_abnormal_immune_serum | 2.70885629 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.62297573 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.60974060 |
| 24 | MP0001819_abnormal_immune_cell | 2.59824056 |
| 25 | MP0002229_neurodegeneration | 2.49670088 |
| 26 | MP0005423_abnormal_somatic_nervous | 2.39079311 |
| 27 | MP0002653_abnormal_ependyma_morphology | 2.34257805 |
| 28 | MP0005451_abnormal_body_composition | 2.18806823 |
| 29 | MP0003763_abnormal_thymus_physiology | 2.17269013 |
| 30 | MP0006082_CNS_inflammation | 2.07951342 |
| 31 | MP0002398_abnormal_bone_marrow | 2.04728705 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 2.01719884 |
| 33 | MP0000716_abnormal_immune_system | 2.00828487 |
| 34 | MP0003011_delayed_dark_adaptation | 11.0004356 |
| 35 | MP0002405_respiratory_system_inflammati | 1.98902647 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.95962443 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.95401820 |
| 38 | MP0002752_abnormal_somatic_nervous | 1.90430988 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.83217436 |
| 40 | MP0001764_abnormal_homeostasis | 1.79439742 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.70537153 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.68509359 |
| 43 | MP0001873_stomach_inflammation | 1.68355675 |
| 44 | MP0002722_abnormal_immune_system | 1.66327657 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.65770236 |
| 46 | MP0002132_abnormal_respiratory_system | 1.62874064 |
| 47 | MP0002429_abnormal_blood_cell | 1.61361693 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.57755113 |
| 49 | MP0006292_abnormal_olfactory_placode | 1.51844212 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.50078754 |
| 51 | MP0004947_skin_inflammation | 1.45430623 |
| 52 | MP0000858_altered_metastatic_potential | 1.42793995 |
| 53 | MP0004381_abnormal_hair_follicle | 1.41989995 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.41690531 |
| 55 | MP0003866_abnormal_defecation | 1.39825584 |
| 56 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37635549 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.37204229 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.36372517 |
| 59 | MP0005310_abnormal_salivary_gland | 1.35976914 |
| 60 | MP0005394_taste/olfaction_phenotype | 1.27625589 |
| 61 | MP0005499_abnormal_olfactory_system | 1.27625589 |
| 62 | MP0008469_abnormal_protein_level | 1.26190450 |
| 63 | MP0004510_myositis | 1.25568780 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.25302082 |
| 65 | MP0008789_abnormal_olfactory_epithelium | 1.23289541 |
| 66 | MP0005197_abnormal_uvea_morphology | 1.13864153 |
| 67 | MP0009764_decreased_sensitivity_to | 1.12690035 |
| 68 | MP0000490_abnormal_crypts_of | 1.03840057 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.03546813 |
| 70 | MP0004885_abnormal_endolymph | 1.02281014 |
| 71 | MP0001851_eye_inflammation | 0.99289213 |
| 72 | MP0004233_abnormal_muscle_weight | 0.96055326 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 0.95035650 |
| 74 | MP0004019_abnormal_vitamin_homeostasis | 0.93800336 |
| 75 | MP0002254_reproductive_system_inflammat | 0.92805605 |
| 76 | MP0004883_abnormal_blood_vessel | 0.89390312 |
| 77 | MP0003828_pulmonary_edema | 0.88559469 |
| 78 | MP0002166_altered_tumor_susceptibility | 0.86815175 |
| 79 | MP0004858_abnormal_nervous_system | 0.86400461 |
| 80 | MP0010030_abnormal_orbit_morphology | 0.85040297 |
| 81 | MP0001984_abnormal_olfaction | 0.84336033 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.83162355 |
| 83 | MP0001663_abnormal_digestive_system | 0.79872080 |
| 84 | MP0006035_abnormal_mitochondrial_morpho | 0.79841548 |
| 85 | MP0003634_abnormal_glial_cell | 0.78107752 |
| 86 | MP0008874_decreased_physiological_sensi | 0.76529192 |
| 87 | MP0002396_abnormal_hematopoietic_system | 0.74604003 |
| 88 | MP0003690_abnormal_glial_cell | 0.74511557 |
| 89 | MP0005166_decreased_susceptibility_to | 0.74103334 |
| 90 | MP0009763_increased_sensitivity_to | 0.74094356 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.73979723 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.73116793 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.73116793 |
| 94 | MP0003787_abnormal_imprinting | 0.72561121 |
| 95 | MP0000604_amyloidosis | 0.72560374 |
| 96 | MP0005390_skeleton_phenotype | 0.70977230 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.69147652 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.68069652 |
| 99 | MP0003329_amyloid_beta_deposits | 0.66836624 |
| 100 | MP0001286_abnormal_eye_development | 0.65575483 |
| 101 | MP0003878_abnormal_ear_physiology | 0.63251182 |
| 102 | MP0005377_hearing/vestibular/ear_phenot | 0.63251182 |
| 103 | MP0005187_abnormal_penis_morphology | 0.61676495 |
| 104 | MP0002697_abnormal_eye_size | 0.61409468 |
| 105 | MP0001853_heart_inflammation | 0.61288934 |
| 106 | MP0002138_abnormal_hepatobiliary_system | 0.58810825 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.58663951 |
| 108 | MP0000343_altered_response_to | 0.57543925 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.57403279 |
| 110 | MP0001293_anophthalmia | 0.56243678 |
| 111 | MP0002933_joint_inflammation | 0.54979084 |
| 112 | MP0003448_altered_tumor_morphology | 0.54949877 |
| 113 | MP0003303_peritoneal_inflammation | 0.54425838 |
| 114 | MP0000313_abnormal_cell_death | 0.52836248 |
| 115 | MP0001849_ear_inflammation | 0.51829632 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.51500153 |
| 117 | MP0000750_abnormal_muscle_regeneration | 0.51301571 |
| 118 | MP0001915_intracranial_hemorrhage | 0.50149354 |
| 119 | MP0002234_abnormal_pharynx_morphology | 0.49925885 |
| 120 | MP0005248_abnormal_Harderian_gland | 0.48333353 |
| 121 | MP0002272_abnormal_nervous_system | 0.47843391 |
| 122 | MP0001486_abnormal_startle_reflex | 0.47458299 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.47402588 |
| 124 | MP0005193_abnormal_anterior_eye | 0.46164842 |
| 125 | MP0004859_abnormal_synaptic_plasticity | 0.46152491 |
| 126 | MP0003880_abnormal_central_pattern | 0.44241451 |
| 127 | MP0000631_abnormal_neuroendocrine_gland | 0.42603336 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.40989407 |
| 129 | MP0003635_abnormal_synaptic_transmissio | 0.39608148 |
| 130 | MP0002064_seizures | 0.36797941 |
| 131 | MP0004270_analgesia | 0.36484250 |
| 132 | MP0002102_abnormal_ear_morphology | 0.36268455 |
| 133 | MP0001968_abnormal_touch/_nociception | 0.36079791 |
| 134 | MP0000569_abnormal_digit_pigmentation | 0.35481117 |
| 135 | MP0003172_abnormal_lysosome_physiology | 0.34688090 |
| 136 | MP0002067_abnormal_sensory_capabilities | 0.32050001 |
| 137 | MP0002092_abnormal_eye_morphology | 0.30829881 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.30685312 |
| 139 | MP0004811_abnormal_neuron_physiology | 0.30641492 |
| 140 | MP0001963_abnormal_hearing_physiology | 0.29531422 |
| 141 | MP0002089_abnormal_postnatal_growth/wei | 0.29506383 |
| 142 | MP0009046_muscle_twitch | 0.29207399 |
| 143 | MP0002184_abnormal_innervation | 0.27519905 |
| 144 | MP0002734_abnormal_mechanical_nocicepti | 0.27194049 |
| 145 | MP0009278_abnormal_bone_marrow | 0.26817759 |
| 146 | MP0002152_abnormal_brain_morphology | 0.26588820 |
| 147 | MP0008995_early_reproductive_senescence | 0.26485872 |
| 148 | MP0005595_abnormal_vascular_smooth | 0.25715020 |
| 149 | MP0003436_decreased_susceptibility_to | 0.25537236 |
| 150 | MP0005376_homeostasis/metabolism_phenot | 0.24951438 |
| 151 | MP0003638_abnormal_response/metabolism_ | 0.24842285 |
| 152 | MP0002877_abnormal_melanocyte_morpholog | 0.24586851 |
| 153 | MP0003890_abnormal_embryonic-extraembry | 0.24047654 |
| 154 | MP0003183_abnormal_peptide_metabolism | 0.22628540 |
| 155 | MP0009780_abnormal_chondrocyte_physiolo | 0.21343721 |
| 156 | MP0002063_abnormal_learning/memory/cond | 0.20299514 |
| 157 | MP0010386_abnormal_urinary_bladder | 0.19100540 |
| 158 | MP0008569_lethality_at_weaning | 0.18858431 |
| 159 | MP0002928_abnormal_bile_duct | 0.18282446 |
| 160 | MP0003075_altered_response_to | 0.18208804 |
| 161 | MP0004130_abnormal_muscle_cell | 0.16984495 |
| 162 | MP0005464_abnormal_platelet_physiology | 0.16800234 |
| 163 | MP0008007_abnormal_cellular_replicative | 0.16627549 |
| 164 | MP0008004_abnormal_stomach_pH | 0.16508641 |
| 165 | MP0003943_abnormal_hepatobiliary_system | 0.16366651 |
| 166 | MP0001835_abnormal_antigen_presentation | 0.16140183 |
| 167 | MP0009333_abnormal_splenocyte_physiolog | 0.15665799 |
| 168 | MP0003861_abnormal_nervous_system | 0.15402167 |
| 169 | MP0004808_abnormal_hematopoietic_stem | 0.14405996 |
| 170 | MP0005386_behavior/neurological_phenoty | 0.14273893 |
| 171 | MP0004924_abnormal_behavior | 0.14273893 |
| 172 | MP0001270_distended_abdomen | 0.14144294 |
| 173 | MP0001614_abnormal_blood_vessel | 0.14008212 |
| 174 | MP0003045_fibrosis | 0.13857142 |
| 175 | MP0002572_abnormal_emotion/affect_behav | 0.13732605 |
| 176 | MP0002066_abnormal_motor_capabilities/c | 0.11818482 |
| 177 | MP0000428_abnormal_craniofacial_morphol | 0.11638949 |
| 178 | MP0000778_abnormal_nervous_system | 0.11558846 |
| 179 | MP0003633_abnormal_nervous_system | 0.11489171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chorioretinal atrophy (HP:0000533) | 8.86547017 |
| 2 | Pigmentary retinal degeneration (HP:0001146) | 8.85701926 |
| 3 | Pendular nystagmus (HP:0012043) | 8.59010984 |
| 4 | Central scotoma (HP:0000603) | 8.49124518 |
| 5 | Abolished electroretinogram (ERG) (HP:0000550) | 7.62463104 |
| 6 | Scotoma (HP:0000575) | 7.38789484 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 7.33568081 |
| 8 | Dyschromatopsia (HP:0007641) | 7.06304012 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 6.77377519 |
| 10 | Eczematoid dermatitis (HP:0000976) | 6.73141578 |
| 11 | Decreased central vision (HP:0007663) | 6.08721370 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 5.84758474 |
| 13 | Posterior subcapsular cataract (HP:0007787) | 5.79992637 |
| 14 | Recurrent abscess formation (HP:0002722) | 5.72960678 |
| 15 | Type II diabetes mellitus (HP:0005978) | 5.64351274 |
| 16 | Abnormality of macrophages (HP:0004311) | 5.54424550 |
| 17 | Severe visual impairment (HP:0001141) | 5.50588580 |
| 18 | * Photophobia (HP:0000613) | 5.27029834 |
| 19 | Macular degeneration (HP:0000608) | 5.24239687 |
| 20 | Increased corneal curvature (HP:0100692) | 5.23907434 |
| 21 | Keratoconus (HP:0000563) | 5.23907434 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 4.94100357 |
| 23 | Myositis (HP:0100614) | 4.91053055 |
| 24 | Vitreoretinal degeneration (HP:0000655) | 4.90897709 |
| 25 | Cone-rod dystrophy (HP:0000548) | 4.81550030 |
| 26 | Constricted visual fields (HP:0001133) | 4.73871278 |
| 27 | Stomatitis (HP:0010280) | 4.69684327 |
| 28 | Obstructive lung disease (HP:0006536) | 4.53685310 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 4.53685310 |
| 30 | Orchitis (HP:0100796) | 4.53050418 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 4.43992001 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.36811851 |
| 33 | Meningitis (HP:0001287) | 4.36490018 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.33427137 |
| 35 | Optic neuritis (HP:0100653) | 4.28467236 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 4.28467236 |
| 37 | Recurrent fungal infections (HP:0002841) | 4.20756336 |
| 38 | Retinitis pigmentosa (HP:0000510) | 4.12522013 |
| 39 | Choroideremia (HP:0001139) | 3.92682425 |
| 40 | Vasculitis (HP:0002633) | 3.86848531 |
| 41 | Recurrent skin infections (HP:0001581) | 3.77586986 |
| 42 | Urticaria (HP:0001025) | 3.67756631 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 3.62544929 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.62544929 |
| 45 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.56040506 |
| 46 | Increased IgM level (HP:0003496) | 3.55717505 |
| 47 | Cellulitis (HP:0100658) | 3.48195122 |
| 48 | Chest pain (HP:0100749) | 3.46388580 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46133689 |
| 50 | Increased IgE level (HP:0003212) | 3.45778282 |
| 51 | Encephalitis (HP:0002383) | 3.43388221 |
| 52 | Gingivitis (HP:0000230) | 3.39681514 |
| 53 | Subcapsular cataract (HP:0000523) | 3.37990312 |
| 54 | Progressive visual loss (HP:0000529) | 3.33237804 |
| 55 | Gastrointestinal stroma tumor (HP:0100723) | 3.30929128 |
| 56 | * Lymphopenia (HP:0001888) | 3.19878598 |
| 57 | Recurrent viral infections (HP:0004429) | 2.97146721 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.92335893 |
| 59 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.89267394 |
| 60 | IgM deficiency (HP:0002850) | 2.86643685 |
| 61 | Pulmonary infiltrates (HP:0002113) | 2.85475319 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.84680412 |
| 63 | Hemoptysis (HP:0002105) | 2.83343807 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 2.82693937 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.79093869 |
| 66 | Inflammation of the large intestine (HP:0002037) | 2.71056622 |
| 67 | Hypochromic anemia (HP:0001931) | 2.70628980 |
| 68 | Keratoconjunctivitis (HP:0001096) | 2.68090252 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.63867485 |
| 70 | Wide nasal bridge (HP:0000431) | 2.60168906 |
| 71 | Episodic fever (HP:0001954) | 2.57341609 |
| 72 | Retinal atrophy (HP:0001105) | 2.56212440 |
| 73 | Sepsis (HP:0100806) | 2.55091178 |
| 74 | Anorexia (HP:0002039) | 2.53431369 |
| 75 | Colitis (HP:0002583) | 2.48595982 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.48474353 |
| 77 | Restrictive lung disease (HP:0002091) | 2.43702035 |
| 78 | T lymphocytopenia (HP:0005403) | 2.42619653 |
| 79 | Osteomyelitis (HP:0002754) | 2.41872210 |
| 80 | Arterial thrombosis (HP:0004420) | 2.40631358 |
| 81 | Leukocytosis (HP:0001974) | 2.35916779 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.34748081 |
| 83 | Pustule (HP:0200039) | 2.34303746 |
| 84 | Optic disc pallor (HP:0000543) | 2.33500495 |
| 85 | Abnormality of T cells (HP:0002843) | 2.33243653 |
| 86 | Premature loss of primary teeth (HP:0006323) | 2.32442776 |
| 87 | Amyloidosis (HP:0011034) | 2.32408241 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.31508455 |
| 89 | Hepatosplenomegaly (HP:0001433) | 2.29490229 |
| 90 | Abnormality of the pleura (HP:0002103) | 2.27310029 |
| 91 | Petechiae (HP:0000967) | 2.26713377 |
| 92 | Recurrent pneumonia (HP:0006532) | 2.20428136 |
| 93 | Abnormality of T cell number (HP:0011839) | 2.17110473 |
| 94 | Pulmonary embolism (HP:0002204) | 2.16254731 |
| 95 | Amaurosis fugax (HP:0100576) | 2.15777255 |
| 96 | Prolonged bleeding time (HP:0003010) | 2.15172232 |
| 97 | Peripheral hypomyelination (HP:0007182) | 2.12534038 |
| 98 | Peritonitis (HP:0002586) | 2.11548813 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 2.09846499 |
| 100 | Acute hepatic failure (HP:0006554) | 2.09007133 |
| 101 | Loss of speech (HP:0002371) | 2.08864944 |
| 102 | Neuronal loss in central nervous system (HP:0002529) | 2.08542173 |
| 103 | Papilloma (HP:0012740) | 2.05056624 |
| 104 | Verrucae (HP:0200043) | 2.05056624 |
| 105 | Keratitis (HP:0000491) | 2.04458282 |
| 106 | Hypertensive crisis (HP:0100735) | 2.03705289 |
| 107 | Recurrent lower respiratory tract infections (HP:0002783) | 2.02993997 |
| 108 | Gangrene (HP:0100758) | 2.02018297 |
| 109 | Hypermelanotic macule (HP:0001034) | 2.01331856 |
| 110 | Abnormality of T cell physiology (HP:0011840) | 2.00509363 |
| 111 | Congenital stationary night blindness (HP:0007642) | 13.7109451 |
| 112 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 11.1869625 |
| 113 | Bony spicule pigmentary retinopathy (HP:0007737) | 11.1061514 |
| 114 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.4665961 |
| 115 | Granulocytopenia (HP:0001913) | 1.99536574 |
| 116 | Papilledema (HP:0001085) | 1.99387237 |
| 117 | Emphysema (HP:0002097) | 1.98051773 |
| 118 | Gingival bleeding (HP:0000225) | 1.98020503 |
| 119 | Skin rash (HP:0000988) | 1.97302697 |
| 120 | Epistaxis (HP:0000421) | 1.94887617 |
| 121 | * Recurrent sinusitis (HP:0011108) | 1.94226867 |
| 122 | Skin ulcer (HP:0200042) | 1.92966390 |
| 123 | Glomerulopathy (HP:0100820) | 1.92894309 |
| 124 | IgG deficiency (HP:0004315) | 1.91348002 |
| 125 | Viral hepatitis (HP:0006562) | 1.90488386 |
| 126 | Gait imbalance (HP:0002141) | 1.89968529 |
| 127 | Polar cataract (HP:0010696) | 1.88206263 |
| 128 | Ankle clonus (HP:0011448) | 1.87403970 |
| 129 | Congenital primary aphakia (HP:0007707) | 1.87173244 |
| 130 | Arthralgia (HP:0002829) | 1.85160698 |
| 131 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84636272 |
| 132 | Purpura (HP:0000979) | 1.83864430 |
| 133 | Microcytic anemia (HP:0001935) | 1.80769303 |
| 134 | Congenital sensorineural hearing impairment (HP:0008527) | 1.71822002 |
| 135 | Optic atrophy (HP:0000648) | 1.63891084 |
| 136 | Nephrogenic diabetes insipidus (HP:0009806) | 1.62356536 |
| 137 | Medial flaring of the eyebrow (HP:0010747) | 1.49903188 |
| 138 | Horizontal nystagmus (HP:0000666) | 1.43925883 |
| 139 | True hermaphroditism (HP:0010459) | 1.40933472 |
| 140 | Vaginal atresia (HP:0000148) | 1.31948863 |
| 141 | Poor coordination (HP:0002370) | 1.31916248 |
| 142 | Severe Myopia (HP:0011003) | 1.28150023 |
| 143 | Genital tract atresia (HP:0001827) | 1.24284798 |
| 144 | Visual hallucinations (HP:0002367) | 1.16449558 |
| 145 | Pancreatic fibrosis (HP:0100732) | 1.16405068 |
| 146 | Abnormality of the fovea (HP:0000493) | 1.15633687 |
| 147 | Sclerocornea (HP:0000647) | 1.15624755 |
| 148 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.14531550 |
| 149 | Albinism (HP:0001022) | 1.14060880 |
| 150 | Increased cerebral lipofuscin (HP:0011813) | 1.13402849 |
| 151 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.11464977 |
| 152 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.08209398 |
| 153 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.08167482 |
| 154 | Insomnia (HP:0100785) | 1.07212995 |
| 155 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.06183622 |
| 156 | Hypoplasia of the fovea (HP:0007750) | 1.06183622 |
| 157 | Cystic liver disease (HP:0006706) | 1.04745962 |
| 158 | Retinal detachment (HP:0000541) | 1.01814280 |
| 159 | Hypermetropia (HP:0000540) | 1.01154793 |
| 160 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.00613023 |
| 161 | Epileptic encephalopathy (HP:0200134) | 0.96791844 |
| 162 | Chorioretinal coloboma (HP:0000567) | 0.96452321 |
| 163 | Pancreatic cysts (HP:0001737) | 0.94648842 |
| 164 | Anophthalmia (HP:0000528) | 0.92895720 |
| 165 | Abnormal gallbladder physiology (HP:0012438) | 0.92343677 |
| 166 | Cholecystitis (HP:0001082) | 0.92343677 |
| 167 | Abnormality of the lower motor neuron (HP:0002366) | 0.92078673 |
| 168 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.91814107 |
| 169 | Dysdiadochokinesis (HP:0002075) | 0.91383084 |
| 170 | Hypoventilation (HP:0002791) | 0.90743843 |
| 171 | Hyperacusis (HP:0010780) | 0.89502230 |
| 172 | Cerebellar dysplasia (HP:0007033) | 0.87062978 |
| 173 | Abdominal situs inversus (HP:0003363) | 0.86384638 |
| 174 | Abnormality of abdominal situs (HP:0011620) | 0.86384638 |
| 175 | Supranuclear gaze palsy (HP:0000605) | 0.85471770 |
| 176 | Decreased testicular size (HP:0008734) | 0.82115345 |
| 177 | Depression (HP:0000716) | 0.81687422 |
| 178 | Truncal ataxia (HP:0002078) | 0.81524256 |
| 179 | Astigmatism (HP:0000483) | 0.79469037 |
| 180 | Furrowed tongue (HP:0000221) | 0.78289001 |
| 181 | Elfin facies (HP:0004428) | 0.78270001 |
| 182 | Left ventricular hypertrophy (HP:0001712) | 0.76492612 |
| 183 | Macroorchidism (HP:0000053) | 0.76228140 |
| 184 | Specific learning disability (HP:0001328) | 0.74762645 |
| 185 | Febrile seizures (HP:0002373) | 0.74466476 |
| 186 | Hand muscle atrophy (HP:0009130) | 0.73728558 |
| 187 | Asthma (HP:0002099) | 0.72291096 |
| 188 | Heterotopia (HP:0002282) | 0.69889293 |
| 189 | Broad foot (HP:0001769) | 0.69542963 |
| 190 | Renovascular hypertension (HP:0100817) | 0.66476976 |
| 191 | Septo-optic dysplasia (HP:0100842) | 0.66221910 |
| 192 | Molar tooth sign on MRI (HP:0002419) | 0.65600479 |
| 193 | Abnormality of midbrain morphology (HP:0002418) | 0.65600479 |
| 194 | Anencephaly (HP:0002323) | 0.65434312 |
| 195 | Abnormality of the fingertips (HP:0001211) | 0.65021780 |
| 196 | Progressive cerebellar ataxia (HP:0002073) | 0.63283065 |
| 197 | Pallor (HP:0000980) | 0.60086161 |
| 198 | Inappropriate behavior (HP:0000719) | 0.59823689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 9.62356676 |
| 2 | RIPK4 | 4.62381012 |
| 3 | MAP3K10 | 3.68299664 |
| 4 | PBK | 3.34755878 |
| 5 | IRAK4 | 3.02416802 |
| 6 | IRAK2 | 2.92637577 |
| 7 | PRPF4B | 2.80136564 |
| 8 | PINK1 | 2.47437193 |
| 9 | SIK2 | 2.40843572 |
| 10 | PKN2 | 2.39885420 |
| 11 | SCYL2 | 2.33713241 |
| 12 | MAP2K3 | 2.30931190 |
| 13 | TYK2 | 2.28986241 |
| 14 | SIK3 | 2.28212091 |
| 15 | CSK | 2.13468969 |
| 16 | GRK6 | 2.11547702 |
| 17 | TRIB3 | 1.98378007 |
| 18 | SMG1 | 1.98089715 |
| 19 | EPHB1 | 1.93412649 |
| 20 | CDK12 | 1.89093913 |
| 21 | TAOK1 | 1.88436949 |
| 22 | FGR | 1.74571855 |
| 23 | HIPK2 | 1.69370905 |
| 24 | MAP3K11 | 1.67573130 |
| 25 | ICK | 1.67189979 |
| 26 | CAMK1G | 1.58180104 |
| 27 | PAK6 | 1.55582898 |
| 28 | CAMK1D | 1.53389602 |
| 29 | RPS6KA4 | 1.51903486 |
| 30 | MAP4K1 | 1.51776658 |
| 31 | TESK2 | 1.50752478 |
| 32 | HCK | 1.47947444 |
| 33 | JAK3 | 1.46252851 |
| 34 | ZAP70 | 1.43086514 |
| 35 | NEK2 | 1.40549854 |
| 36 | MAP3K14 | 1.34195779 |
| 37 | NEK1 | 1.33322643 |
| 38 | TBK1 | 1.28695858 |
| 39 | FES | 1.26254464 |
| 40 | IKBKE | 1.25297755 |
| 41 | MARK2 | 1.22468781 |
| 42 | LYN | 1.22258685 |
| 43 | JAK2 | 1.19928404 |
| 44 | ADRBK1 | 1.18195054 |
| 45 | EEF2K | 1.15494161 |
| 46 | MATK | 1.12993275 |
| 47 | CSF1R | 1.09669515 |
| 48 | ERBB2 | 1.05251949 |
| 49 | MAP3K3 | 1.05236425 |
| 50 | TXK | 1.03952717 |
| 51 | TAOK3 | 1.03566972 |
| 52 | MAP3K1 | 1.03471062 |
| 53 | ALK | 1.02997138 |
| 54 | BRD4 | 1.00185543 |
| 55 | CAMKK1 | 0.98049698 |
| 56 | LRRK2 | 0.96493616 |
| 57 | PRKD3 | 0.95425446 |
| 58 | MAP3K13 | 0.93438631 |
| 59 | FGFR4 | 0.93273269 |
| 60 | PRKCH | 0.91276327 |
| 61 | LCK | 0.91095773 |
| 62 | MAPK12 | 0.91054598 |
| 63 | JAK1 | 0.89116613 |
| 64 | YES1 | 0.88460951 |
| 65 | MARK1 | 0.87216617 |
| 66 | DYRK1B | 0.85633802 |
| 67 | CDK9 | 0.83102024 |
| 68 | TGFBR1 | 0.82356248 |
| 69 | PRKCZ | 0.80386090 |
| 70 | ITK | 0.78476870 |
| 71 | EPHA3 | 0.78222247 |
| 72 | BCKDK | 0.78139413 |
| 73 | MAP3K4 | 0.76497589 |
| 74 | IRAK1 | 0.75079647 |
| 75 | CCNB1 | 0.75050183 |
| 76 | TNK2 | 0.74548490 |
| 77 | RET | 0.73644350 |
| 78 | TESK1 | 0.73242904 |
| 79 | CSNK1D | 0.70721050 |
| 80 | IKBKB | 0.70629052 |
| 81 | BMPR2 | 0.70001593 |
| 82 | ARAF | 0.68831595 |
| 83 | MAP3K5 | 0.65764046 |
| 84 | MAPK7 | 0.65729385 |
| 85 | ERN1 | 0.65580735 |
| 86 | DYRK1A | 0.64386891 |
| 87 | MINK1 | 0.63259736 |
| 88 | PDPK1 | 0.62276778 |
| 89 | MARK3 | 0.62230351 |
| 90 | BLK | 0.62109813 |
| 91 | PNCK | 0.60982053 |
| 92 | RPS6KA2 | 0.59689553 |
| 93 | RIPK1 | 0.58941793 |
| 94 | PASK | 0.58602534 |
| 95 | SGK494 | 0.56951536 |
| 96 | SGK223 | 0.56951536 |
| 97 | PRKCB | 0.56294895 |
| 98 | STK38 | 0.55810904 |
| 99 | PRKACG | 0.51585286 |
| 100 | GRK5 | 0.51386090 |
| 101 | BTK | 0.51318409 |
| 102 | SIK1 | 0.50235626 |
| 103 | PTK6 | 0.49073625 |
| 104 | KIT | 0.48570027 |
| 105 | MAPK9 | 0.46889175 |
| 106 | CAMK1 | 0.46289419 |
| 107 | MAP3K9 | 0.44440226 |
| 108 | PRKCQ | 0.44404306 |
| 109 | RPS6KL1 | 0.43490863 |
| 110 | RPS6KC1 | 0.43490863 |
| 111 | PRKAA1 | 0.42967936 |
| 112 | DYRK3 | 0.42636517 |
| 113 | KSR1 | 0.42308257 |
| 114 | RPS6KB2 | 0.41767410 |
| 115 | MAPK14 | 0.41550086 |
| 116 | CDC42BPA | 0.40641462 |
| 117 | MAP2K6 | 0.40022487 |
| 118 | KSR2 | 0.39559462 |
| 119 | RPS6KA3 | 0.39234178 |
| 120 | PRKD2 | 0.38764406 |
| 121 | STK10 | 0.38000757 |
| 122 | MAP3K7 | 0.37766636 |
| 123 | PIM1 | 0.37747275 |
| 124 | RPS6KB1 | 0.37370359 |
| 125 | DYRK2 | 0.37006812 |
| 126 | GSK3B | 0.36456834 |
| 127 | CDK4 | 0.36324743 |
| 128 | ERBB3 | 0.36291178 |
| 129 | PRKDC | 0.36148945 |
| 130 | SYK | 0.35656198 |
| 131 | AKT2 | 0.34858805 |
| 132 | CDK3 | 0.34712962 |
| 133 | MAP2K4 | 0.34383723 |
| 134 | SGK3 | 0.33826869 |
| 135 | CDK7 | 0.33801005 |
| 136 | UHMK1 | 0.33362168 |
| 137 | STK11 | 0.31970832 |
| 138 | CAMK4 | 0.31803284 |
| 139 | CAMKK2 | 0.31746656 |
| 140 | RAF1 | 0.31434983 |
| 141 | TLK1 | 0.30428483 |
| 142 | PRKCD | 0.30186993 |
| 143 | CDK1 | 0.30147182 |
| 144 | MAPK3 | 0.29192041 |
| 145 | FGFR1 | 0.29037425 |
| 146 | CDK19 | 0.28513897 |
| 147 | CDK5 | 0.28159278 |
| 148 | TAOK2 | 0.27766363 |
| 149 | PDK1 | 0.26569321 |
| 150 | MAP2K7 | 0.25808976 |
| 151 | FGFR3 | 0.24600201 |
| 152 | TGFBR2 | 0.24574016 |
| 153 | MAP3K6 | 0.23493243 |
| 154 | ILK | 0.22913553 |
| 155 | FYN | 0.22108011 |
| 156 | PRKD1 | 0.21950729 |
| 157 | CDK2 | 0.21910224 |
| 158 | MAPK10 | 0.21773631 |
| 159 | CDK11A | 0.21739217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.11079747 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.00711784 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.76700066 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.58821963 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.32712846 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29204768 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 2.07649824 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 15.2824062 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98283365 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.93412324 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93284551 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.86858280 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84483051 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.79691332 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65214813 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.57654338 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56433469 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.55817385 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53340709 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52659062 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.52032896 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45840334 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43302839 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42738637 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39435280 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30774914 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.28789672 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.27957608 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25013731 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.24522920 |
| 31 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.23243438 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.23206830 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20941441 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.13459629 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.12093529 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11665200 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.09117431 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07842622 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97303401 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96808905 |
| 41 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96568205 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90614365 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.90261585 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.89292573 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87667835 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85921542 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84979357 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 0.83839772 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83044537 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82503073 |
| 51 | Morphine addiction_Homo sapiens_hsa05032 | 0.82348996 |
| 52 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.82322581 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81085336 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80682392 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79996217 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78033248 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74699450 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73486103 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73294686 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72546304 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.71704431 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71459242 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68987269 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68012843 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66184930 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65107778 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61795939 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59685093 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58116701 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57975775 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56922104 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56559696 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.56363364 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55532553 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55098751 |
| 76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54665572 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54107466 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49249060 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.48916551 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48625501 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48571219 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47100169 |
| 83 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46349389 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46101624 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46053104 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44301623 |
| 87 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43940356 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43389558 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42748714 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42010556 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41359864 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41028540 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39440628 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.39346706 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.39261528 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37677589 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37440415 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35497757 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34852992 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34842043 |
| 101 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.34580644 |
| 102 | Purine metabolism_Homo sapiens_hsa00230 | 0.34320564 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.34167501 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33944385 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33704113 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33349375 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31686557 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31655761 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31469628 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31020525 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30749434 |
| 112 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.30428080 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29637508 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29432260 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29376308 |
| 116 | Nicotine addiction_Homo sapiens_hsa05033 | 0.28877619 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28050184 |
| 118 | Salivary secretion_Homo sapiens_hsa04970 | 0.27390393 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27216040 |
| 120 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26939520 |
| 121 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26368581 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26057111 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25850644 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25715196 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25171883 |
| 126 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24786982 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.24312372 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.23522754 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23357471 |
| 130 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23074442 |
| 131 | Spliceosome_Homo sapiens_hsa03040 | 0.22860867 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22152842 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21433170 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21343027 |
| 135 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21211697 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.20222419 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20050763 |
| 138 | Cocaine addiction_Homo sapiens_hsa05030 | 0.19060801 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.18924033 |
| 140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18556634 |
| 141 | Lysine degradation_Homo sapiens_hsa00310 | 0.18525723 |
| 142 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.18390722 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18142852 |
| 144 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.17921851 |
| 145 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17718145 |
| 146 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17670636 |
| 147 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17654915 |
| 148 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.17626186 |
| 149 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17196453 |
| 150 | Endocytosis_Homo sapiens_hsa04144 | 0.15405954 |
| 151 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.15297929 |
| 152 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.14193323 |
| 153 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.14141530 |
| 154 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.13775162 |
| 155 | Tuberculosis_Homo sapiens_hsa05152 | 0.13218667 |
| 156 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.11833099 |
| 157 | RNA degradation_Homo sapiens_hsa03018 | 0.11345452 |
| 158 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.11036567 |
| 159 | Leishmaniasis_Homo sapiens_hsa05140 | 0.10055080 |
| 160 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.09987609 |

